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Abstract
Mitochondrial calcium uptake is present in nearly all vertebrate tissues and is believed to be critical in shaping calcium
signaling, regulating ATP synthesis and controlling cell death. Calcium uptake occurs through a channel called the uniporter
that resides in the inner mitochondrial membrane. Recently, we used comparative genomics to identify MICU1 and MCU as
the key regulatory and putative pore-forming subunits of this channel, respectively. Using bioinformatics, we now report
that the human genome encodes two additional paralogs of MICU1, which we call MICU2 and MICU3, each of which likely
arose by gene duplication and exhibits distinct patterns of organ expression. We demonstrate that MICU1 and MICU2 are
expressed in HeLa and HEK293T cells, and provide multiple lines of biochemical evidence that MCU, MICU1 and MICU2
reside within a complex and cross-stabilize each other’s protein expression in a cell-type dependent manner. Using in vivo
RNAi technology to silence MICU1, MICU2 or both proteins in mouse liver, we observe an additive impairment in calcium
handling without adversely impacting mitochondrial respiration or membrane potential. The results identify MICU2 as a
new component of the uniporter complex that may contribute to the tissue-specific regulation of this channel.
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Introduction
The ability of mitochondria to transport calcium is thought to
be fundamental for the regulation of cellular bioenergetics [1,2]
and cell death [3,4]. Mitochondrial calcium uptake and buffering
enable these organelles to shape cytosolic calcium transients,
resulting in mitochondrial control over key biological processes,
including neurotransmission and hormone secretion [5,6]. The
primary route of calcium uptake is via a low affinity calcium
‘‘uniporter’’ located in the inner mitochondrial membrane [7,8].
This channel mechanism, defined by its dependence on mito-
chondrial membrane potential, sensitivity to Ru-360 [9] and
activation at micromolar calcium concentrations, was first
characterized in isolated mitochondria in 1961 [7,8]. In subse-
quent decades, the biophysical properties of the mitochondrial
calcium uniporter were extensively characterized [10,11], but its
molecular identity remained elusive.
Recently, we coupled observations from comparative physiology
with integrative genomics to identify two proteins required for
normal mitochondrial calcium handling: MICU1 [12] and MCU
[13]. Based on sequence analysis and functional studies, we
hypothesized that MCU is the channel-forming subunit of the
uniporter, whereas MICU1 fulfilled important criteria for a
regulatory protein. This model has been corroborated by
independent and complementary studies [14,15,16]. Additional
studies point to the central role of MICU1 in calcium-mediated
insulin signaling [15] and provide evidence that MICU1 may set
the calcium threshold for MCU-mediated calcium uptake [16].
For many decades, it has been known that the uniporter exhibits
tissue specific regulatory properties [10,17] whose molecular basis
remains to be elucidated. Interestingly, genome sequence analysis
reveals that the human genome harbors two additional MICU1
homologs, called EFHA1 and EFHA2, neither of which has been
previously studied. Both of these proteins have mitochondrial
targeting sequences and were previously identified with high and
low confidence, respectively, in MitoCarta, our proteomic
characterization of mitochondria from 14 different tissues [18].
Here, we pursue an initial characterization of one of these
proteins, EFHA1, which we now re-name MICU2.
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Materials and Methods
Ethics Statement
All procedures used in animal studies were performed at
Alnylam Pharmaceuticals in strict accordance with local and
national recommendations and have been approved by the
Institutional Animal Care and Use Committee (AAALAC Unit
Number 001345, NIH assurance number A4517-01).
Multiple sequence alignment
Sequences were downloaded from the NCBI protein database.
ClustalW2 was used to perform a multiple sequence alignment and
generate a phylogenetic tree.
RNA expression analysis
Data from a publicly available mouse gene expression atlas were
downloaded (GEO accession number GSE10246) [19] and
summarized using gcRMA normalization [20].
Cell culture
HeLa and HEK293T cells were received from the ATCC.
HeLa cells expressing aequorin targeted to the mitochondrial
matrix (mt-AEQ) were purchased from Aequotech (AT-002-H).
All cells were grown at 37uC and 5% CO2 in Dulbecco’s modified
Eagle medium (DMEM) (Invitrogen 11995) with 10% FBS (Sigma
F6178). HeLa cells expressing mt-AEQ were maintained in
100 mg/ml of geneticin.
Confocal imaging
HeLa cells were co-transfected with plasmids containing
carboxy terminus GFP-tagged MICU2 or Mito-HcRed1 (Clon-
tech 632434). Twenty-four hours after transfection, cells were
washed three times with PBS and imaged using a Leica TCS SP5
confocal microscope.
Quantitative Real-Time PCR
RNA was isolated from HEK293T cells using a Qiagen RNeasy
kit and was reverse-transcribed using SuperScript III following the
manufacturers’ protocols. Quantitative real-time PCR (qPCR) was
performed using Taqman assays targeting MICU1
(Hs00381563_m1), MICU2 (Hs0246104_m1) and b-actin (Ap-
plied Biosystems Human ACTB #4352935E). Experiments were
performed in technical triplicate.
Immunoprecipitation
Mitochondria were isolated from HEK293T cells that stably
express Flag-tagged GFP targeted to mitochondria, MCU-Flag or
FLAG-MICU1. 200 mg of protein were solubilized with 200 ml of
lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 5 mM
EDTA, 0.2% DDM and protease inhibitor tablets (Roche Applied
Science 118361170001)) for 10 minutes at 4uC. Lysates were
cleared by spinning at 16000 g for 10 minutes at 4uC. Cleared
lysates were incubated with anti-Flag M2 affinity gel (Sigma
A2220) in PBS for 2 hours at 4uC. Immunoprecipitates were
washed with 1 ml of lysis buffer 3 times and boiled in 30 ml of
sample buffer. One third of the immunoprecipitate was loaded on
a 12% SDS-PAGE gel for detection of the indicated proteins.
MCU antibody was generated in chicken, MICU1 antibody was
generated in rabbit and MICU2 antibody was purchased from
Abcam (ab101465). Control antibodies ATP5A (MS507), ATP5B
(MS503) and SDHB (MS203) were purchased from MitoSciences.
Synthesis and selection of siRNA duplexes targeting
MICU1 and MICU2
48 and 20 siRNAs were selected for synthesis and screening
based on low predicted off-target potentials and 100% homology
with mouse sequences NM_144822.2 and NM_028643.3, respec-
tively. Single-strand RNAs were produced at Alnylam Pharma-
ceuticals as previously described [21]. Hepa-1c1c7 cells seeded at
15,000 cells per well in 96-well plates were transfected with
siRNAs using Lipofectamine RNAiMAX according to the
manufacturer’s protocols. Each experiment was performed in
technical duplicate. 18–24 h post-transfection, MICU1 and
MICU2 mRNA levels were quantified using a branched-DNA
assay (QuantiGene Reagent System, Panomics) according to the
manufacturer’s protocols. Their mRNA levels were normalized to
GAPDH mRNA.
In vivo silencing of MICU1 and MICU2
C57BL/6 mice (Charles River Laboratories) received either
PBS or siRNA in lipidoid formulations via weekly tail vein
injections as previously described [13,22,23,24]. After overnight
fasting, the animals were euthanized by CO2 inhalation and the
livers were harvested and stored in ice-cold PBS prior to
mitochondria isolation. A piece of liver tissue was snap-frozen in
liquid nitrogen for mRNA analysis.
Mitochondrial Isolation
Mitochondria were isolated from mouse liver as previously
described [25] and resuspended in a buffer containing 220 mM
mannitol, 75 mM sucrose, 10 mM HEPES and 1 mM EDTA
adjusted to pH 7.4 with KOH and supplemented with fresh 0.2%
BSA prior to use. Mitochondria were stored on ice until further
use.
Measurement of mitochondrial respiration, membrane
potential and calcium uptake
Respiration and membrane potential were measured optically
as previously described [25]. Values for respiratory control ratios
(RCR) and ADP:O (P:O) ratios represent the mean +/2 s.d. of
three independent experiments performed on n= 3 mice. Calcium
uptake experiments were performed on a Perkin-Elmer Envision
plate reader and Perkin Elmer LS-50B fluorescence spectrometer
as previously described [13]. Inset reports linear fits between 5 and
10 s from experiments performed on n=3 mice.
RNA interference
To silence MICU1, we used short-hairpin RNA (shRNA)
constructs TRCN0000053370 (59-GCAATGGCGAACTGAG-
CAATA-39, shMICU1a) and TRCN0000053368 (59-GCAGCT-
CAAGAAGCACTTCAA-39, shMICU1b) from the Broad Insti-
tute’s RNAi Consortium (TRC) previously validated in mt-AEQ
HeLa cells. To silence MICU2, we used shRNA constructs
TRCN0000055848 (59-GCCATGCAGATGTTCAGTTTA-39,
shMICU2a) and TRCN0000055850 (GCTGCAGAAGATCA-
TAAGTAA, shMICU2b). As controls, shRNAs targeting GFP,
RFP and LACZ were used. All shRNAs were provided in a
lentiviral vector (pLKO.1) through the TRC. Lentiviral produc-
tion and infection were performed as previously described [26].
Cells were selected 24 hours after infection with 2 mg/ml of
puromycin.
cDNA rescue experiments
A lentiviral vector (pLEX983) for expressing C-terminal V5-
tagged cDNA was obtained from the TRC. Full-length MICU2
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cDNA was synthesized (Blue Heron Biotechnology) and cloned
into pLEX983. Lentivirus was produced using cDNAs encoding
GFP, MICU2 or MICU1 resistant to TRCN0000053370 as
previously described [26]. Virus was used to infect HeLa cells
stably expressing mt-AEQ. Cells were selected 24 hours after
infection with 5 mg/ml of blasticidin.
Measurement of mitochondrial calcium in HeLa cells
expressing mt-AEQ
40,000 cells were seeded in a 96-well plate and incubated
overnight. Mitochondrial calcium was measured following hista-
mine treatment as previously described [27]. Light emission was
measured at 469 nm every 0.1 s using a luminometer (MicroBeta2
LumiJET Microplate Counter PerkinElmer). Luminescence was
normalized to account for cell number.
Blue native PAGE studies
5 mg of mitochondria isolated from mouse liver or HeLa cells
were solubilized in 2% digitonin on ice for 30 minutes. Electro-
phoresis was performed using the Novex NativePAGE Bis-Tris
Gel System from Invitrogen. Western blot analysis was performed
using an MCU antibody generated in chicken. A commercially
available antibody to ATP5A (MitoSciences MS507) was used as a
loading control.
Results
MICU1, MICU2 and MICU3 form a family of paralogous
genes
We previously used comparative genomics to identify MICU1,
a mitochondrial protein essential for mitochondrial calcium
handling in HeLa cells [12]. MICU1 (previously known as
CBARA1 or EFHA3) has a mitochondrial targeting sequence as
well as two evolutionarily conserved EF hands. Sequence analysis
reveals that MICU1 shares approximately 25% sequence identity
with two human genes, EFHA1 and EFHA2, which have not been
studied before. These three proteins are conserved in vertebrates,
whereas only one homolog is present in plants and protozoa.
To elucidate the evolutionary relationship of these three
proteins, we performed a multiple sequence alignment using
homologs from vertebrates, plants and protozoa. This analysis
placed the protozoa and plant homologs as outgroups on a
phylogenetic tree (Fig. 1a), indicating that EFHA1 and EFHA2 are
vertebrate paralogs of MICU1 that likely arose from a gene
duplication event prior to vertebrate evolution. We now re-name
EFHA1 as MICU2 and EFHA2 as MICU3.
Like MICU1, MICU2 and MICU3 have N-terminal targeting
sequences consistent with mitochondrial localization [28]. In our
previous proteomic studies, MICU2 and MICU3 were detected in
mitochondria from various mouse tissues, although their expres-
sion patterns differed significantly [18]. MICU1 was broadly
expressed and detected in 12 out of 14 mouse tissues, whereas
MICU2 was detected in 7 out of 14 tissues with strong expression
in visceral organs. In contrast, MICU3 was found in 6 out of 14
tissues with a strong signature in skeletal muscle and the central
nervous system. Despite being detected in multiple mouse tissues,
MICU3 lacked other evidence of being mitochondrial, scoring just
below the stringent threshold required to be a part of the
MitoCarta collection. This is in contrast to MICU2, which was
Figure 1. MICU2 is paralogous to MICU1 and localizes to
mitochondria. A. MICU1, MICU2 and MICU3 share a common ancestor
and are present in multiple vertebrate species. B. RNA expression
analysis of MICU1, MICU2, MICU3 and MCU across 21 mouse tissues. For
each tissue, the dots represent individual replicate measures and the
bars represent mean values. C. MICU2 has two evolutionarily conserved
EF hands. D. Representative confocal images of HeLa cells cotransfected
with MICU2-GFP and Mito-HcRed1.
doi:10.1371/journal.pone.0055785.g001
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reported in MitoCarta and localized to the mitochondria using
high-content microscopy to visualize its subcellular localization.
Analysis of published microarrays of MICU1-3 across 21
different mouse tissues revealed a similar expression pattern as
predicted by MitoCarta (Fig. 1b). MICU2 was strongly expressed
in visceral organs whereas MICU3 was expressed almost
exclusively in neural tissues and skeletal muscle (Fig. 1b). In the
present study, we focus on MICU2 due to greater expression in
visceral organs in which we can apply in vivo siRNA technology to
achieve silencing.
Sequence comparison of human MICU1 and MICU2 reveals
highly conserved domain architecture (Fig. 1c). Similar to MICU1,
MICU2 has two EF-hands separated by a long stretch of residues
predicted to form a-helices. In previous work, we showed that the
calcium-coordinating residues in the EF-hands of MICU1 are
highly conserved across species [12]. Likewise, MICU2 demon-
strates perfect conservation in the acidic residues that cap the EF-
hands across evolution (Fig. 1c).
MICU2-GFP localizes exclusively to mitochondria
We began by confirming that MICU2-GFP localizes exclusively
to mitochondria with confocal microscopy, which showed that a
carboxy terminus GFP-tagged MICU2 overlapped with mito-
chondrial marker Mito-HcRed1 (Fig. 1d).
MICU1 and MICU2 stabilize each other’s protein
expression
In previous studies, we demonstrated that MICU1 regulates
mitochondrial calcium handling in HeLa cells [12]. Since MICU1
and MICU2 are paralogs with conserved domain architecture, it is
possible that they have redundant roles and are expressed in a
mutually exclusive manner across different cell types. To address
this possibility, we blotted whole cell lysate from HEK293T and
HeLa cells for MICU1 and MICU2, which revealed expression of
both proteins (Fig. 2a, S1, S2a). Interestingly, in the setting of
MICU1 knockdown, there was a significant reduction in MICU2
protein expression in both HEK293T and HeLa cells despite
preserved MICU2 RNA levels (Fig. 2a, S2a). This phenomenon
was observed following treatment with multiple hairpins (shMI-
CU1a and shMICU1b), indicating that this result is a biological
consequence of MICU1 loss rather than an off target effect.
Conversely, overexpression of MICU1 in HEK293T resulted in
higher levels of MICU2 (Fig. 2b). Interestingly, in the setting of
MICU2 knockdown, a reduction of MICU1 was observed in
HeLa cells (Fig. S2a) whereas no effect on MICU1 expression was
observed in HEK293T cells (Fig. 2a). This discrepancy may reflect
additional mechanisms contributing to MICU1 stability in
HEK293T cells. Collectively, these studies demonstrate that
MICU1 and MICU2 are expressed in multiple cell types and
that their protein expression is contingent on one another.
MICU2 associates with the MICU1/MCU complex
In our previous studies, we demonstrated that MICU1 and
MCU physically interact either directly or indirectly [13]. To
determine whether MICU2 physically interacts with these
proteins, we performed immunoprecipitation on cells stably
expressing either MCU-FLAG or GFP-FLAG. Although endog-
enous MICU1 and MICU2 were present in cell lysate from both
cell lines, immunoprecipitation with an anti-FLAG antibody
specifically recovered MICU1 and MICU2 from the MCU-FLAG
cell line (Fig. 2c). It is notable that the heterologous expression of
MCU-FLAG resulted in increased protein expression of both
MICU1 and MICU2 as seen in the whole cell lysate (Fig. 2c),
suggesting that MCU overexpression stabilizes the protein
expression of MICU1 and MICU2. In addition, immunoprecip-
itation performed on cells stably expressing either MICU1-FLAG
or GFP-FLAG demonstrated specific recovery of MICU2 with
MICU1 in the presence of excess calcium or EGTA (Fig. 2d).
Collectively, these results (Fig. 2a–d) strongly support the notion
that MICU1, MICU2 and MCU physically interact to form a
complex.
MICU1 and MICU2 can be silenced in vivo in mouse liver
using siRNA technology
Our sequence analysis, expression analysis and biochemical
data motivated us to pursue studies in which we could directly
assess the contribution of MICU2 to mitochondrial calcium
uptake. To evaluate the impact of MICU2 loss on mitochondrial
calcium uptake, we performed in vivo silencing of MICU2 in mouse
liver using technology developed by Alnylam Pharmaceuticals
[13]. Since a key question was whether MICU1 and MICU2
Figure 2. MICU1 and MICU2 stabilize each other’s expression
and interact with MCU. A. Whole cell lysates from HEK293T cells
stably expressing a control shRNA (shGFP and shLACZ) or a shRNA
targeting MICU1 (shMICU1a and shMICU1b) or MICU2 (shMICU2a) were
analyzed using qPCR and western blot. The relative mRNA is reported
using b-actin as an endogenous control and normalized to shGFP for
each target. Whole cell lysates were blotted with anti-MICU1, anti-
MICU2 and control anti-ATP5A. B. Whole cell lysates from HEK293T cells
stably expressing FLAG-GFP or FLAG-MICU1 were lysed and blotted
with anti-MICU2, anti-FLAG and control anti-ATP5A. C–D. Mitochondria
isolated from HEK293T cells stably expressing MCU-FLAG (C) or FLAG-
MICU1 (D) were solubilized with 0.2% DDM and subjected to anti-FLAG
immunoprecipitation. Immunoprecipitates and lysate were blotted with
anti-FLAG, anti-MICU1, anti-MICU2 and control anti-ATP5B and anti-
SDHB.
doi:10.1371/journal.pone.0055785.g002
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contribute independently to mitochondrial calcium uptake, we
also performed in vivo silencing of MICU1 in isolation and in
combination with MICU2.
We screened siRNA duplexes for both genes using previously
described siRNA design and delivery technology [13]. Duplexes
were transfected at concentrations from 1.25 to 5 nM, and the 3
siRNAs conferring the best knockdown were tested at different
concentrations in the range of 7pM to 5 nM to estimate their EC50
in a mouse liver cell line (Fig. 3a). As a negative control, we used a
siRNA duplex that targets firefly luciferase (siLUC). We performed
a large-scale synthesis of one siRNA duplex and encapsulated it
into a lipid-based formulation optimized for liver-specific delivery.
Although mRNA knockdown was achieved at 24 hours, weekly
tail vein injections of the siRNA duplexes were carried out over a
six-week period to achieve in vivo knockdown of MICU1 and
MICU2 (Fig. 3b). Similar to in vivo silencing of MCU [13], mice
did not exhibit any signs of distress. Their weight was stable, and
the gross appearance of their livers did not differ.
Mitochondrial membrane potential and respiration are
intact following in vivo silencing of MICU1/MICU2 in
mouse liver
We evaluated the impact of silencing MICU1 and MICU2 on
mitochondrial respiration and membrane potential (Ym) to ensure
that silencing did not cause respiratory chain collapse leading to a
secondary defect in calcium uptake. Mitochondria isolated from
control and knockdown livers underwent robust respiratory
transitions as demonstrated by their comparable respiratory
control ratios (RCR) (Fig. 3c, e). In addition, comparable ADP:O
ratios indicate intact ATP-coupled mitochondrial respiration.
Together, these results indicate that silencing MICU1 or MICU2
did not alter baseline mitochondrial respiration or oxidative
phosphorylation. In mitochondria isolated from all treatment
groups, membrane potential was responsive to ADP and fully
depolarized by the uncoupler carbonyl cyanide m-chlorophenyl-
hydrazone (CCCP), indicating that silencing MICU1 or MICU2
did not abolish the mitochondrial membrane potential (Fig. 3d). It
is notable that these findings are similar to what we previously
reported for in vivo silencing of MCU in mouse liver [13].
In vivo silencing of MICU1 and MICU2 in mouse liver
results in altered mitochondrial calcium handling
Next, we analyzed calcium uptake kinetics in mitochondria
isolated from control and knockdown mice. We added a single,
large 50 mM spike of calcium to mitochondria suspended in buffer
containing extramitochondrial Calcium Green-5N (CG5N) and
observed the rate of calcium clearance by measuring CG5N
fluorescence. Mitochondria from siMICU1 and siMICU2 mice
demonstrated moderately impaired calcium uptake kinetics
whereas mitochondria from siMICU1+siMICU2 mice demon-
strated an additive defect (Fig. 4a). This result was also observed
when multiple spikes of calcium were added to mitochondria
(Fig. 4b). Interestingly, knockdown mitochondria were unable to
fully buffer a second pulse of calcium, whereas control mitochon-
dria rapidly buffered the entire pulse (Fig. 4b). Knockdown
mitochondria demonstrated premature release of calcium, sug-
gesting that knockdown mitochondria were sensitized to release
calcium (Fig. 4b). In addition, MCU protein expression was
significantly decreased in knockdown mitochondria (Fig. 4c). The
degree of MCU protein loss correlated with the phenotype
strength, raising the question of whether MCU loss was
responsible for at least part of the observed phenotype. Similar
to the effect of MICU2 knockdown in HeLa cells, loss of MICU2
in mouse liver resulted in decreased expression of MICU1 to about
half of wild-type levels (densitometry not shown). By extending the
phenomenon of cross-stabilization to mouse tissues, this result
strongly suggests that a fundamental role of these paralogs is
stabilizing each other’s protein expression.
In vivo silencing of MICU1 and MICU2 alters MCU
complex size
In previous studies, we demonstrated that MCU is present in a
complex of approximately 480 kDa using blue native polyacryl-
amide gel electrophoresis (BN-PAGE) and western blot (WB)
analysis [13]. To gain insight into how silencing these proteins may
Figure 3. MICU1 and MICU2 can be silenced in vivo in mouse
liver using siRNA technology. A. In vitro dose-response curves of
selected duplexes targeting MICU1 and MICU2. B. Relative expression of
MICU1 and MICU2 mRNA after 6 weekly injections normalized to siLUC
mice. C. Representative oxygen consumption traces measured in
isolated mitochondria from siLUC (top) and siMICU1+2 (bottom) mice.
Arrows denote addition of mitochondria, glutamate and malate (G/M),
ADP and uncoupler (carbonyl cyanide m-chlorophenylhydrazone,
CCCP). Respiratory control ratios (RCR) and ADP:O ratios (P:O) were
calculated from experiments performed on three separate mice per
group. D. Representative mitochondrial membrane potential traces
measured in isolated mitochondria from siLUC (top) and siMICU1+2
(bottom) mice using tetramethyl rhodamine methyl ester (TMRM). E.
Respiratory control ratios (RCR) and ADP:O ratios (P:O) were comparable
among all treatment groups.
doi:10.1371/journal.pone.0055785.g003
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affect the uniporter complex, we solubilized control and knock-
down mitochondria in digitonin and performed BN-PAGE and
western blot analysis, which revealed decreased levels of MCU
complex in knockdown mitochondria (Fig. 4d). In addition,
blotting with anti-MCU revealed a shift in MCU complex size
in knockdown mitochondria relative to siLUC (Fig. 4d). The
percentage of shifted MCU complex was greater in si-MICU1
mitochondria compared to si-MICU2 mitochondria. The basis for
this difference is unclear, but it may reflect less efficient MICU2
knockdown or increased sensitivity of the uniporter complex to
MICU1 loss relative to MICU2 loss. Interestingly, the degree of
shift correlated with the severity of calcium uptake. This result was
also observed in human cell lines stably expressing shMICU1a and
shLZ (Fig. S2b). The shift in the MCU complex size could be
rescued by introducing a cDNA encoding MICU1 that was
resistant to shRNA degradation, suggesting that this shift was
specific to MICU1 knockdown rather than an off-target effect
(data not shown).
Redundant or complementary roles of MICU1 and
MICU2?
An important question is whether MICU1 and MICU2 have
redundant or complementary roles in mitochondrial calcium
uptake. The fact that MICU1 and MICU2 are both expressed in
multiple human cell lines and mouse liver and that simultaneous
silencing results in an additive calcium handling defect suggests
that they contribute independently to mitochondrial calcium
handling. However, the finding that their loss produces similar
defects, including reduced calcium uptake kinetics, premature
calcium release and a shift in the MCU complex size, indicates
that they may have overlapping molecular roles in mitochondrial
calcium handling.
To explore this question, we used a commercially available mt-
AeQ HeLa reporter cell line that reports matrix free calcium. In
this background, we stably expressed a shRNA targeting MICU1,
which resulted in a severely diminished rise in free matrix calcium
following histamine stimulation as we previously reported [12].
Subsequently, we introduced a cDNA encoding either MICU1
(with synonymous mutations at the shRNA sites) or MICU2. As
expected, MICU1 robustly restored the rise in matrix calcium
following histamine stimulation (Fig. S2c). Although expression of
MICU2 rescued the calcium phenotype, it also restored MICU1
protein levels to approximately half of wild-type levels (Fig. S2c, d).
This result precluded a definitive evaluation of whether MICU2
could compensate for MICU1 because it could be explained by
multiple mechanisms, including MICU2 stabilizing low levels of
remaining MICU1 or directly replacing MICU1 as a functional
paralog. In contrast to mitochondria isolated from mouse liver, it is
important to point out that MICU1 knockdown does not result in
decreased MCU expression in cultured HeLa cells (Fig. S2d),
which may reflect cell-type differential regulation.
Discussion
Mitochondrial calcium transport is a highly conserved phe-
nomenon that is linked to a diverse set of cellular processes,
including cellular metabolism [2,5] and programmed cell death
[4,26]. Given the lack of cell-permeant uniporter inhibitors and
the previously unknown molecular identity of the uniporter, the
functional studies to date have been largely correlative. The
discovery of MICU1 and MCU [12,13] opens the door to an
endless set of targeted genetic and biochemical studies that will
enable a detailed molecular understanding of mitochondrial
calcium uptake and the mechanisms that govern its regulation.
MICU1 is a part of a duplicated gene family found in all major
branches of life, including metazoans, plants, protozoa and fungi,
with lineage specific losses [29]. In the current paper, we show that
MICU1, MICU2 and MICU3 are conserved in vertebrates and
that they exhibit distinct patterns of expression (Fig. 1b), suggesting
complementary roles in controlling uniporter physiology. Based on
MitoCarta, MICU2 is a high confidence mitochondrial-localized
protein whereas MICU3 is likely mitochondrial but with lower
confidence [18]. We prioritized MICU2 for functional studies, but
MICU3 likely has a role in mitochondrial calcium handling in a
subset of tissues, notably in the CNS and skeletal muscle, though
this remains to be formally proven. Although we showed in
previous work that loss of MICU1 in HeLa cells results in impaired
mitochondrial calcium handling [12], it was unclear if this
property extended to other cell types. Our current study extends
Figure 4. Silencing MICU1 and MICU2 results in impaired
calcium handling and alters MCU complex size in mouse liver.
A. Calcium uptake in energized liver mitochondria following the
addition of 50 mM CaCl2. Inset reports linear fits of uptake between 5
and 10 s normalized to siLUC uptake. B. Calcium uptake in energized
liver mitochondria following the addition of multiple spikes of 50 mM
CaCl2. C. Mouse liver mitochondria isolated from animals treated with
siLUC, siMICU1, siMICU2 or siMICU1+2 were blotted with anti-MICU1,
anti-MCU and control anti-ATP5A. D. BN-PAGE analysis of mouse liver
mitochondria isolated from animals treated with siLUC, siMICU1,
siMICU2 or siMICU1+2. Protein was transferred to a membrane and
blotted with anti-MCU and control anti-ATP5A.
doi:10.1371/journal.pone.0055785.g004
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this finding to mouse liver, establishing the central role of MICU1
in calcium handling in mammalian mitochondria.
Our biochemical and genetic studies strongly support the notion
that MCU, MICU1 and MICU2 reside within a complex. This
idea is supported by co-IP experiments as well as by the novel
observation of cross-stabilization of these proteins. This was most
evident in HEK293T cells in which we performed the majority of
our biochemical experiments. Silencing MICU1 resulted in loss of
MICU2 protein (Fig. 2c), and forced expression of either MICU1
or MCU led to apparent stabilization of MICU1 and MICU2
protein (Fig. 2b, c). Similar effects are observed in HeLa cells,
where MICU1 protein levels were also sensitive to MICU2
knockdown (Fig. S2a). In mouse liver, we observed that silencing
MICU1 or MICU2 led to a shift in the large molecular weight
MCU complex (Fig. 4d) previously described [13]. Together, these
studies reveal that MICU2 is a genuine member of the uniporter
complex.
At present, the precise molecular function of MICU1, MICU2
and MICU3 remain unclear. In this study, we performed in vivo
silencing of MICU1 and MICU2, which resulted in reduced
mitochondrial calcium clearance in response to large 50 mM
calcium pulses. Given the reconstitution data suggesting that
MCU is the pore-forming subunit of the uniporter, possible roles
for MICU2 could include: (i) Ca2+ sensing and regulation of
MCU, (ii) calcium buffering with a secondary impact on transport
or (iii) assembly and stabilization of MCU. A recent study provides
compelling evidence that MICU1 sets the threshold for mito-
chondrial calcium uptake without affecting the kinetics properties
of the pore [16]. How MICU2 contributes to this mechanism
remains an important outstanding question.
Although our results show that MICU1 and MICU2 play
complementary roles at a physiological level, it remains unclear
whether they have distinct or redundant molecular functions. The
evolutionary conservation of MICU1, MICU2 and MICU3 in
vertebrates, their distinct patterns of expression across organs and
the presence of MICU1 and MICU2 in two different cell types
indicate complementary roles in cellular physiology. However, it is
unclear if they are redundant on a molecular level. We attempted
to complement a strong MICU1 phenotype in HeLa cells that we
previously reported by expressing MICU2 on a MICU1 knock-
down background. Although MICU2 was able to rescue this
phenotype, we found that MICU2 also stabilized the protein
expression of the small amount of MICU1 (Fig. S2d), confounding
the interpretation. Resolving this question will require the use of a
null genetic background in which the activity of one paralog can
be rigorously assessed in the absence of the other paralog.
Our biochemical findings have important implications for the
interpretation of functional studies of the uniporter that employ
genetic silencing or overexpression. The current study demon-
strates that when uniporter protein components are genetically
silenced, this perturbation may impact the protein stability of
companion proteins, and that cross-stabilization may represent a
cell-type specific phenomenon. For example, forced expression of
MCU has been reported to give a gain of function phenotype, yet
we observe that forced expression of MCU also leads to elevated
levels of MICU1 and MICU2 in HEK293T cells (Fig. 2c).
Silencing of MICU1 and MICU2, either alone or in combination,
in mouse liver appears to have an impact on the abundance of
MCU protein levels (Fig. 4c), which likely contributed to decreased
mitochondrial calcium clearance in these assays (Fig. 4a, b). Cross-
stabilization is not unusual in large, protein complexes, including
those of the respiratory chain, where the expression of subunits is
nucleated and stabilized by other partners. Future studies of the
uniporter need to be cognizant of the ability of MCU, MICU1,
and MICU2 to impact each other’s protein expression, as genetic
silencing studies may misattribute a molecular function to the
target protein when indeed the impact may be indirect. In
addition, it will be important to consider other mechanisms,
including those involving MCUR1 [30], LETM1 [31] and NCLX
[32] that may additionally influence mitochondrial calcium
physiology.
It is tempting to speculate that the relative expression of
MICU1, MICU2 and MICU3 differ in a cell and state-specific
manner to regulate mitochondrial calcium handling. Under this
model, multiple paralogs could be constitutively expressed in a
single cell type, but variation in their relative abundance could give
rise to functional differences in mitochondrial calcium handling, as
has been previously documented across tissues [10,17]. If this
model proves to be correct, it may open up the possibility of
therapeutically targeting the uniporter in a tissue specific manner.
Supporting Information
Figure S1 Antibodies for MICU1 and MICU2 do not
cross-react. Whole cell lysates from HEK293T cells stably
expressing a control shRNA (shLZ) or shRNA targeting MICU1
(shMICU1a) or MICU2 (shMICU2a) were blotted with anti-
MICU1, anti-MICU2 and control anti-ATP5A.
(TIF)
Figure S2 Analysis of MICU1, MICU2 and MCU in HeLa
cells. A. Whole cell lysates from HeLa cells stably expressing a
control shRNA (shGFP and shLACZ) or a shRNA targeting
MICU1 (shMICU1a and shMICU1b) or MICU2 (shMICU2a and
shMICU2b) were blotted with anti-MICU1, anti-MICU2 and
control anti-ATP5A. B. BN-PAGE analysis of mitochondria
isolated from HeLa cells stably expressing shGFP or shMICU1a.
Protein was transferred to a membrane and blotted with anti-
MCU and control anti-ATP5A. C. Luminescence measurements
of mitochondrial matrix calcium following histamine stimulation
in HeLa cells stably expressing aequorin targeted to the
mitochondrial matrix (mean 6 s.e.m., n=4). Inset reports statistics
on the maximal luminescence (mean 6 s.d., n = 8, *P,0.001). D.
Western blot analysis of cells stably expressing shGFP and GFP,
shMICU1a and GFP, shMICU1a and MICU1-V5 or shMICU1a
and MICU2-V5.
(TIF)
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